Philips Healthcare and preclinical technology developer Bruker BioSpin have inked a memorandum of understanding to develop magnetic particle imaging (MPI) scanners for the preclinical market.
Under the terms of the deal, Bruker BioSpin said it intends to develop and manufacture MPI scanners designed for preclinical use at its facilities in Ettingen, Germany. Both firms will comarket the resulting product.
MPI uses the magnetic properties of iron-oxide nanoparticles to produce 3D images of nanoparticle concentration after injection into the bloodstream, according to Philips of Andover, MA, and Bruker BioSpin. The companies believe the development of MPI technology will help researchers gain new information on disease processes at the organ, cellular, and molecular level.
Related Reading
Philips teams with Maquet, debuts cardiac tool, September 22, 2009
Philips launches OB ultrasound reporting package, August 27, 2009
Philips updates Xcelera for cardiology, ships CT scanner worldwide, August 19, 2009
Road to RSNA, MRI, Bruker BioSpin, November 10, 2005
Copyright © 2009 AuntMinnie.com
